Anixa Biosciences Stock Today
| ANIX Stock | USD 2.85 0.08 2.73% |
Performance0 of 100
| Odds Of DistressLess than 46
|
Anixa Biosciences is trading at 2.85 as of the 13th of December 2024; that is 2.73 percent decrease since the beginning of the trading day. The stock's open price was 2.93. Anixa Biosciences has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 24th of December 2022 and ending today, the 13th of December 2024. Click here to learn more.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California. Anixa Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 32.18 M outstanding shares of which 369.03 K shares are presently shorted by private and institutional investors with about 3.03 trading days to cover. More on Anixa Biosciences
Follow Valuation Odds of Bankruptcy
Fiscal Year End 21st of January 2025
Anixa Stock Highlights
| Chairman | Amit Kumar |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
Anixa Biosciences (ANIX) is traded on NASDAQ Exchange in USA. It is located in 3150 Almaden Expressway, San Jose, CA, United States, 95118 and employs 4 people. Anixa Biosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 94.61 M. Anixa Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 32.18 M outstanding shares of which 369.03 K shares are presently shorted by private and institutional investors with about 3.03 trading days to cover.
Anixa Biosciences currently holds about 31.66 M in cash with (6.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03.
Check Anixa Biosciences Probability Of Bankruptcy
Ownership AllocationAnixa Biosciences holds a total of 32.18 Million outstanding shares. Anixa Biosciences shows 5.05 percent of its outstanding shares held by insiders and 17.4 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Anixa Ownership Details
Anixa Biosciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Anixa Biosciences market risk premium is the additional return an investor will receive from holding Anixa Biosciences long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.67) | |||
| Treynor Ratio | (0.27) |
Anixa Stock Against Markets
Already Invested in Anixa Biosciences?
The danger of trading Anixa Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Anixa Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Anixa Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Anixa Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.